New research points to treatment breakthrough for viruses

July 12, 2017
influenza
Electron microscopy of influenza virus. Credit: CDC

RMIT University scientists in Melbourne, Australia, have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.

The results are published today in the prestigious scientific and medical journal Nature Communications.

Each year the flu sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50.

The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.

The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O'Leary from Trinity College Dublin, Monash University's Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause in humans.

The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans.

They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.

Once activated, Nox2 oxidase suppresses the body's key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.

The study also investigated a new prototype drug to treat these debilitating .

The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.

Their customised drug was found to be very effective at suppressing disease caused by influenza infection.

Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: "Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.

"We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.

"We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.

"The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.

"This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year."

To said: "This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu."

Professor Calum Drummond, Deputy Vice-Chancellor Research and Innovation and Vice-President at RMIT, said the project held immense promise.

"The unique partnership between Dr Selemidis' laboratory at the School of Health and Biomedical Sciences at RMIT and his collaborators continues.

"Dr Selemidis' laboratory and his collaborators are pursuing further research to aid development of novel drugs for further trials and this is showing great potential," Drummond said.

Explore further: Researchers develop mouse that could provide advance warning of next flu pandemic

Related Stories

Researchers develop mouse that could provide advance warning of next flu pandemic

April 10, 2017
Researchers in Germany have developed a transgenic mouse that could help scientists identify new influenza virus strains with the potential to cause a global pandemic. The mouse is described in a study, "In vivo evasion of ...

Dendritic cells 'divide and conquer' to elude viral infection while promoting immunity

July 7, 2017
A research team led by Jackson Laboratory (JAX) Professor Karolina Palucka, M.D., Ph.D., in collaboration with a research team at Institut Curie in France led by Dr. Nicolas Manel, have addressed a long-standing puzzle of ...

A surprise mechanism uncovered in the development of lupus

October 25, 2012
In a study with a surprising outcome, scientists at Yale School of Medicine have discovered that an enzyme complex known for promoting natural resistance to bacteria and fungi unexpectedly inhibits the development of lupus. ...

New mechanism to control human viral infections discovered

December 5, 2016
A team of researchers, co-led by a University of California, Riverside professor, has found a long-sought-after mechanism in human cells that creates immunity to influenza A virus, which causes annual seasonal epidemics and ...

A single mutation may impact infectivity of West Nile and similar viruses

February 16, 2017
A mutation that impacts changes in the shape of an essential viral protein may influence the infectivity of West Nile and other viruses in the flavivirus family, according to a new study in PLOS Pathogens.

Scientists find new way to mobilize immune system against viruses

May 12, 2014
University of British Columbia scientists have uncovered an intricate chain reaction in the body's immune system and have used the knowledge to develop a new treatment against harmful viruses.

Recommended for you

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.